5^th World Congress on Controversies in Breast Cancer (CoBrCa): When is Less More? will take place September 4 – 6, 2019 in San Francisco, CA, USA and will be hosted by the University of California, San Francisco (UCSF).

The 5^th CoBrCa Congress will continue to directly address key and controversial issues facing clinicians in their daily practice in an effort to find solutions to unresolved clinical and therapeutic problems. Experts will debate, discuss and present lectures on topics in medical oncology, surgery, breast imaging, radiation oncology, pathology, reconstruction and more. At the end of each lecture, the audience will be provided with ample time to join the discussion.

Abstracts should be submitted in English and contain no more than 3,600 characters, including titles, graphs and non-visible characters, such as spaces and line breaks.

Please write concisely and clearly and follow this structure:
Problem statement: Why do we care about the problem?
Methods: What did you actually do to get your results?
Results: What did you learn/invent/create?
Conclusion: What are the implications of your findings?
Please ensure that your abstract does not contain spelling, grammar or scientific mistakes, as it will be reproduced exactly as submitted. No proof reading will be done. Linguistic accuracy is the responsibility of the submitter.
Images/graphs/tables can be uploaded according to the following criteria:

• Width (in pixels): min 50 / max 750
• Height (in pixels): min 50 / max 750
• Size (in KB): min 20/ max 1,000
• Resolution (dpi): min 96 / max 300. The standard display size for images is 96 dpi.
• Format: JPG, PNG or GIF

You may improve the quality of your image for publication by increasing the number of dpi as well as the height and width of the image (in pixels).
If you wish to modify your image, you may use the programme Paint.Net (free software).
Abstract submissions that do not meet the above noted guidelines may be rejected without review.
The Scientific Committee may request additional information about abstracts and reject abstracts.